机构:[1]Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China,[2]Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand,[3]Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China,[4]Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Luzhou, Sichuan, China,[5]South Sichuan Institute of Translational Medicine, Luzhou, Sichuan, China,[6]Department of Pharmacy, University-Town Hospital of Chongqing Medical University, Chongqing, China,[7]Department of Oncology and Hematology, The Affiliated Traditional Chinese Medicine (TCM) Hospital of Southwest Medical University, Luzhou, China,[8]School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China
This work was supported by National Natural Science
Foundation of China (No. 81972643, No. 82172962), Sichuan
Science and Technology Project (2021YJ0201), Luxian People’s
Government and Southwest Medical University Scientific and
Technological Achievements Transfer and Transformation
Strategic Cooperation Project (2019LXXNYKD-07) and
Science and Technology Program of Luzhou, China (No.
2017LZXNYD-Z04, No. 21CGZHPT0001).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|2 区医学
小类|2 区免疫学
最新[2023]版:
大类|2 区医学
小类|2 区免疫学
第一作者:
第一作者机构:[1]Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China,[2]Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand,
共同第一作者:
通讯作者:
通讯机构:[1]Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China,[2]Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand,[3]Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China,[4]Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Luzhou, Sichuan, China,[5]South Sichuan Institute of Translational Medicine, Luzhou, Sichuan, China,
推荐引用方式(GB/T 7714):
Wang Fang,Zheng Anfu,Zhang Duoli,et al.Molecular profiling of core immune-escape genes highlights LCK as an immune-related prognostic biomarker in melanoma[J].Frontiers in immunology.2022,13:1024931.doi:10.3389/fimmu.2022.1024931.
APA:
Wang Fang,Zheng Anfu,Zhang Duoli,Zou Tao,Xiao Mintao...&Xiao Zhangang.(2022).Molecular profiling of core immune-escape genes highlights LCK as an immune-related prognostic biomarker in melanoma.Frontiers in immunology,13,
MLA:
Wang Fang,et al."Molecular profiling of core immune-escape genes highlights LCK as an immune-related prognostic biomarker in melanoma".Frontiers in immunology 13.(2022):1024931